entertainment -WSS

entertainment

author：leisure time 2025-09-30 09:30:07 - browse：43

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Medicare Advantage's lean provider networks lead CMS complaints

focus

WSS

Focused ultrasound for uterine fibroids: an uphill battle

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Take antibiotics after sex, CDC recommends for certain risk groups

Structure Therapeutics oral GLP

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Health insurers say they are turning to AI to cut costs, improve care

hotspot

entertainment

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Malaria cases in Florida and Texas: Here’s what you need to know

Stigma and the return of syphilis

Wildfire smoke exposes gaps in outdoor worker protections

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Medical leaders decry Supreme Court decision on affirmative action

Congress needs to close a vaccine

Medicare details structure of new drug price negotiation program

Insmed lung disease drug hits target in key Phase 3 trial

focus

Take antibiotics after sex, CDC recommends for certain risk groups

Heat waves linked to early deliveries, preterm births in new study

AI used to predict Covid

Childbirth

Insmed lung disease drug hits target in key Phase 3 trial

A new initiative will help leaders fight the next pandemic

entertainment

focus

focus

Wikipedia